46 filings
8-K
ROIV
Roivant Sciences Ltd
2 Apr 24
Other Events
7:10am
8-K
ROIV
Roivant Sciences Ltd
13 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
ROIV
Roivant Sciences Ltd
20 Dec 23
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
5:05pm
8-K/A
ROIV
Roivant Sciences Ltd
20 Dec 23
Financial Statements and Exhibits
4:31pm
8-K
ROIV
Roivant Sciences Ltd
14 Dec 23
Completion of Acquisition or Disposition of Assets
9:17am
8-K
paukylozz qte55
28 Nov 23
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
7:54am
8-K
mw1ln7m
27 Nov 23
Other Events
8:06am
8-K
ib2y9
13 Nov 23
Results of Operations and Financial Condition
7:06am
8-K
8qjdmt9u0ivwumf228
23 Oct 23
Entry into a Material Definitive Agreement
6:00am
8-K
d0qnyt3u9i
29 Sep 23
Entry into a Material Definitive Agreement
4:30pm
8-K
73boup1
26 Sep 23
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
8:00am
8-K
63uhpzguejxt26j9
15 Sep 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
48j6n3oh0
11 Sep 23
Roivant Announces Completion of Redemption of its Outstanding Warrants
8:35am
8-K
6ez5qwy1
17 Aug 23
Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants
4:22pm
8-K
qftyv1y
14 Aug 23
Results of Operations and Financial Condition
7:27am
8-K
5f3lnpb4baszpex5kj4l
4 Aug 23
Departure of Directors or Certain Officers
4:35pm
8-K
axuq8ho o159axxq4i4h
2 Aug 23
Roivant Announces Redemption of Outstanding Warrants
4:26pm
8-K/A
uzq27f6l3
28 Jun 23
Results of Operations and Financial Condition
9:28am
8-K
4bsb2 9qs8n5c13tb2oh
28 Jun 23
Results of Operations and Financial Condition
7:12am
8-K
lev8z89xv5 av573ixo
22 Jun 23
Other Events
7:30am